Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Yongfeng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3787-7773; OpenAlex author ID A5100371430. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 3

  1. COL11A1 acted as a downstream of Mist1 to promote the EMT in pancreatic cancer Co-author DOI 10.21203/rs.3.rs-108113/v1↗
  2. Implantation of radioactive (125)I seeds improves the prognosis of locally advanced pancreatic cancer patients: A retrospective study. Co-author DOI 10.1007/s11596-016-1567-x↗
  3. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Co-author DOI 10.18632/oncotarget.7482↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shanmiao Gou · 3 shared papers, 2016–2020 · strength 0.25
  2. Zhiqiang Liu · 2 shared papers, 2016 · strength 0.13
  3. Heshui Wu · 2 shared papers, 2016 · strength 0.13
  4. Chunyou Wang · 2 shared papers, 2016 · strength 0.13
  5. Yang Li · 1 shared paper, 2020 · strength 0.13
  6. Dianyun Ren · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.